TUCSON, Ariz., – April 11, 2022 – Avery Therapeutics, Inc. (Avery), a privately held, pre-clinical stage therapeutics company, today announced a publication in the peer-reviewed scientific journal, Nature Scientific Reports, outlining a novel technique in cardiac magnetic resonance imaging (CMR) data acquisition utilizing smart-signal gradient recalled echo (GRE)-based array sequences, entitled, “Free-breathing gradient recalled echo-based CMR in a swine heart failure model,” (Morris, el al. (2022). Scientific Reports, 12(1). https://doi.org/10.1038/s41598-022-07611-8). [Read more…]
TreeFrog Therapeutics opens technological hub in Kobe, Japan, to drive partnerships opportunities in the field of iPSC-derived cell therapies
April 8th, 2022, Kobe, Japan – TreeFrog Therapeutics, a French-based biotech company aimed at making safer, more efficient and more affordable cell therapies based on induced pluripotent stem cells (iPSCs), today announced the incorporation of its Japanese subsidiary (KK) TreeFrog Therapeutics Japan and the establishment of a lab in Kobe, at the Creative Lab for Innovation Kobe (CLIK). [Read more…]
AASCP to Host Annual Regenerative Medicine Conference on June 17-19, 2022
April 4 2022, MIAMI, Florida — The American Academy of Stem Cells Physicians is excited to be back at The Hyatt Hotel, this June 17-19, 2022. The conference will focus on the latest state-of-the-art techniques, protocols, and research for 2022. “The Academy for Stem Cell Physicians was founded to advance the field of regenerative medicine and to protect patient access to their individual right to tap into their innate healing abilities,” said Dr. Sunny Kim, President of the AASCP. [Read more…]
PeptiGrowth Inc. is launching a novel synthetic TrkB agonist peptide (BDNF alternative)
April 4, 2022, Tokyo, Japan — PeptiGrowth Inc. (Headquarters: Chiyoda-ku, Tokyo, President: Jiro Sugimoto) has successfully developed a novel TrkB agonist peptide which has the equivalent functions to recombinant Brain Derived Neurotropic Factor (BDNF). We will be marketing this product (BDNF alternative) from the beginning of April, 2022. [Read more…]
